Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000912282-24-000168
Filing Date
2024-02-20
Accepted
2024-02-20 17:17:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d.htm SC 13D 48344
2 image0.jpg GRAPHIC 2915
  Complete submission text file 0000912282-24-000168.txt   54184
Mailing Address 65 QUEEN STREET WEST SUITE 815, P.O. BOX 75 TORONTO A6 M5H 2M5
Business Address 65 QUEEN STREET WEST SUITE 815, P.O. BOX 75 TORONTO A6 M5H 2M5 416-861-5902
Halo Collective Inc. (Filed by) CIK: 0001520211 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0630
Type: SC 13D

Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Subject) CIK: 0001888014 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93857 | Film No.: 24654904
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)